Axol Bioscience

Cambridge, United States

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

Jan 2026

Venture - Series Unknown

Biopharma Biotechnology Medical

Top Investors

Amadeus Capital PartnersSyndicateRoomBroadOak Capital PartnersPar EquityScottish Enterprise

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Axol Bioscience

Who are Axol Bioscience's investors?

Axol Bioscience's investors include Amadeus Capital Partners, SyndicateRoom, BroadOak Capital Partners, Par Equity, Scottish Enterprise.

Where is Axol Bioscience headquartered?

Axol Bioscience is headquartered in Cambridge, United States.

What does Axol Bioscience do?

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

What stage is Axol Bioscience at?

Axol Bioscience is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 13, 2026.

MLA

"Axol Bioscience — Funding & Investors." VCBacked, January 13, 2026, https://www.vcbacked.co/company/axol-bioscience. Accessed July 1, 2026.

APA

VCBacked. (2026). Axol Bioscience — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/axol-bioscience

Wikipedia (cite web)

{{cite web |title=Axol Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/axol-bioscience |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 13, 2026.

Similar Companies in Biopharma

View all

Living In Silico Inc.

Crystalys Therapeutics

San Diego

ARS Pharmaceuticals

San Diego